Inhibikase Therapeutics, Inc. (IKT) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $13.4K | — |
| 2024 | $0 | -100.0% |
| 2023 | $14.2K | -94.1% |
| 2022 | $243.3K | — |
| 2021 | $0 | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $13.4K | — |
| 2024 | $0 | -100.0% |
| 2023 | $14.2K | -94.1% |
| 2022 | $243.3K | — |
| 2021 | $0 | — |